Latest Financial Results News

Saunders International anticipates a weaker first half in FY26 amid ongoing operational challenges but gains momentum with major contracts and strategic expansion into New South Wales.

Kingsrose Mining advances exploration in Norway’s Finnmark region with new geophysical anomalies, while navigating permitting challenges in Finland and focusing on strategic M&A under new leadership.

Mad Paws Holdings reported a robust September quarter with 14% revenue growth and a successful divestment of Pet Chemist, while advancing its acquisition scheme with Rover Group.

Rivco Australia Limited reported a steady quarterly performance with NAV growth and declared its 17th consecutive increasing dividend, while progressing its strategic internalisation.

Otto Energy reported an 11% rise in oil production and a solid US$2 million net operating cash inflow in Q3 2025, alongside key executive and board changes.

Steadfast Group reveals the remuneration package for new Acting CEO Tim Mathieson, highlighting a $1 million fixed salary plus substantial performance incentives for FY26.

Steadfast Group Limited has posted a 17.2% rise in underlying net profit after tax for FY25, marking its 12th consecutive year of growth, even as its CEO steps aside pending an investigation. The company also announced a leadership transition with Vicki Allen named incoming Chair.

Constellation Technologies reports solid first-quarter progress driven by strong demand for its Callisto Food Safety System and new handheld temperature device, alongside promising integration projects and steady revenue.

Novatti Group has achieved positive operating cashflow and EBITDA for the September quarter, driven by strategic revenue reforms and new commercial contracts with major clients.

BSA Limited’s Q1 FY2026 results reveal a sharp revenue drop following the expiration of its key nbn contract, alongside a major workforce reduction and strategic pivot.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Pathkey.AI reports strong validation of its TrialKey AI platform’s predictive accuracy and announces key leadership changes as it advances toward commercial scale.